Christine Brown, PhD, is a faculty member in the Department of Hematology and Hematopoietic Cell Transplantation and the Department of Immuno-Oncology at City of Hope. 
 
As deputy director of the T Cell Therapeutics Research Laboratory, Dr. Brown, the Heritage Provider Network Professor in Immunotherapy, provides scientific oversight for the preclinical research program, as well as the ongoing clinical trial program focused on the development of CAR-engineered T cells for the treatment of hematological malignancies and solid tumors. Dr. Brown’s personal research efforts are focused on developing and refining redirected CAR T cells for the treatment of malignant brain tumors. 
 
Dr. Brown received her PhD from University of California, Berkeley and was a Leukemia and Lymphoma Scholar during her postdoctoral fellowship at Pennsylvania State University. Her scientific contributions to the development and optimization of tumor-specific CAR T cells for the treatment of glioblastoma are supported by the California Institute for Regenerative Medicine and are the basis of an ongoing phase I clinical trial supported by Gateway for Cancer Research and R01 FD005129.